open access

Vol 13, No 3 (2008)
Untitled
Published online: 2008-05-01
Submitted: 2007-05-15
Get Citation

Radiotherapy in metastatic spinal cord compression: a review of fractionation

Thimmaiah NAVEEN, V. LOKESH, Sanjay S. SUPE, K.M. GANESH, Jacob SAMUEL
DOI: 10.1016/S1507-1367(10)60005-3
·
Rep Pract Oncol Radiother 2008;13(3):144-149.

open access

Vol 13, No 3 (2008)
Untitled
Published online: 2008-05-01
Submitted: 2007-05-15

Abstract

Metastatic spinal cord compression, a term normally including compression of the spinal cord or nerve roots running within the spinal canal, is a common complication of systemic cancer, occurring in 5–10% of all patients with cancer. Recent published data on treatment of metastatic spinal cord compression (MSCC) have shown that radiotherapy (RT) alone is an effective approach for the majority of cases. Except for some protocols, the use of conventional RT (daily fractions of 2 Gy to a total dose of 30–40 Gy) has been abandoned in favour of radiation treatment regimens requiring a smaller number of fractions. In some published trials, 4–5 Gy daily for 8 days followed by 4 days rest, and then 5–16 daily doses of 2–3 Gy have been given with both good results and tolerance. Higher daily fractions ranging from 6 to 10 Gy have also been explored with similar results.

We have summarized the studies comparing the treatments and clinical outcome. Most patients with MSCC have a life expectancy of only several months. In these patients one radiotherapeutic schedule with a short overall treatment time would be the best option, if its effect on the most relevant clinical symptoms, pain and motor dysfunction, is comparable to the effect of more protracted schedules. In patients with a reduced life expectancy, a radiotherapeutic effect on recalcification, which can be expected only several months after RT, is of minor importance. In patients with a life expectancy of more than a few months, recalcification becomes more of an issue and a more fractionated radiation schedule should be considered.

Abstract

Metastatic spinal cord compression, a term normally including compression of the spinal cord or nerve roots running within the spinal canal, is a common complication of systemic cancer, occurring in 5–10% of all patients with cancer. Recent published data on treatment of metastatic spinal cord compression (MSCC) have shown that radiotherapy (RT) alone is an effective approach for the majority of cases. Except for some protocols, the use of conventional RT (daily fractions of 2 Gy to a total dose of 30–40 Gy) has been abandoned in favour of radiation treatment regimens requiring a smaller number of fractions. In some published trials, 4–5 Gy daily for 8 days followed by 4 days rest, and then 5–16 daily doses of 2–3 Gy have been given with both good results and tolerance. Higher daily fractions ranging from 6 to 10 Gy have also been explored with similar results.

We have summarized the studies comparing the treatments and clinical outcome. Most patients with MSCC have a life expectancy of only several months. In these patients one radiotherapeutic schedule with a short overall treatment time would be the best option, if its effect on the most relevant clinical symptoms, pain and motor dysfunction, is comparable to the effect of more protracted schedules. In patients with a reduced life expectancy, a radiotherapeutic effect on recalcification, which can be expected only several months after RT, is of minor importance. In patients with a life expectancy of more than a few months, recalcification becomes more of an issue and a more fractionated radiation schedule should be considered.

Get Citation

Keywords

metastatic spinal cord compression; radiotherapy; fractionation; response; toxicity

About this article
Title

Radiotherapy in metastatic spinal cord compression: a review of fractionation

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 13, No 3 (2008)

Pages

144-149

Published online

2008-05-01

DOI

10.1016/S1507-1367(10)60005-3

Bibliographic record

Rep Pract Oncol Radiother 2008;13(3):144-149.

Keywords

metastatic spinal cord compression
radiotherapy
fractionation
response
toxicity

Authors

Thimmaiah NAVEEN
V. LOKESH
Sanjay S. SUPE
K.M. GANESH
Jacob SAMUEL

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl